Your browser doesn't support javascript.
STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol.
van der Feltz-Cornelis, Christina M; Sweetman, Jennifer; Allsopp, Gail; Attree, Emily; Crooks, Michael G; Cuthbertson, Daniel J; Forshaw, Denise; Gabbay, Mark; Green, Angela; Heightman, Melissa; Hillman, Toby; Hishmeh, Lyth; Khunti, Kamlesh; Lip, Gregory Y H; Lorgelly, Paula; Montgomery, Hugh; Strain, W David; Wall, Emma; Watkins, Caroline; Williams, Nefyn; Wootton, Dan G; Banerjee, Amitava.
  • van der Feltz-Cornelis CM; Dept of Health Sciences, University of York, York, United Kingdom.
  • Sweetman J; Hull York Medical School, (HYMS), University of York, York, United Kingdom.
  • Allsopp G; Institute of Health Informatics, University College London, London, United Kingdom.
  • Attree E; Dept of Health Sciences, University of York, York, United Kingdom.
  • Crooks MG; Royal College of General Practitioners, London, United Kingdom.
  • Cuthbertson DJ; National Institute of Health and Care Excellence, London, United Kingdom.
  • Forshaw D; CCG NHS Camden, London, United Kingdom.
  • Gabbay M; Hull York Medical School, University of Hull, Hull, United Kingdom.
  • Green A; Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
  • Heightman M; Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Hillman T; Lancashire Clinical Trials Unit, University of Central Lancashire, Preston, United Kingdom.
  • Hishmeh L; Department of Primary Care & Mental Health, University of Liverpool, Liverpool, United Kingdom.
  • Khunti K; NIHR ARC NWC, Liverpool, United Kingdom.
  • Lip GYH; Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
  • Lorgelly P; Department of Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Montgomery H; Department of Respiratory Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Strain WD; UCL Respiratory, University College London, London, United Kingdom.
  • Wall E; Long COVID SOS, Oxford, United Kingdom.
  • Watkins C; Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, United Kingdom.
  • Williams N; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
  • Wootton DG; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Banerjee A; School of Population Health and Department of Economics, University of Auckland, Auckland, New Zealand.
PLoS One ; 17(11): e0277936, 2022.
Article in English | MEDLINE | ID: covidwho-2140676
ABSTRACT

INTRODUCTION:

As mortality rates from COVID-19 disease fall, the high prevalence of long-term sequelae (Long COVID) is becoming increasingly widespread, challenging healthcare systems globally. Traditional pathways of care for Long Term Conditions (LTCs) have tended to be managed by disease-specific specialties, an approach that has been ineffective in delivering care for patients with multi-morbidity. The multi-system nature of Long COVID and its impact on physical and psychological health demands a more effective model of holistic, integrated care. The evolution of integrated care systems (ICSs) in the UK presents an important opportunity to explore areas of mutual benefit to LTC, multi-morbidity and Long COVID care. There may be benefits in comparing and contrasting ICPs for Long COVID with ICPs for other LTCs. METHODS AND

ANALYSIS:

This study aims to evaluate health services requirements for ICPs for Long COVID and their applicability to other LTCs including multi-morbidity and the overlap with medically not yet explained symptoms (MNYES). The study will follow a Delphi design and involve an expert panel of stakeholders including people with lived experience, as well as clinicians with expertise in Long COVID and other LTCs. Study processes will include expert panel and moderator panel meetings, surveys, and interviews. The Delphi process is part of the overall STIMULATE-ICP programme, aimed at improving integrated care for people with Long COVID. ETHICS AND DISSEMINATION Ethical approval for this Delphi study has been obtained (Research Governance Board of the University of York) as have approvals for the other STIMULATE-ICP studies. Study outcomes are likely to inform policy for ICPs across LTCs. Results will be disseminated through scientific publication, conference presentation and communications with patients and stakeholders involved in care of other LTCs and Long COVID. REGISTRATION Researchregistry https//www.researchregistry.com/browse-the-registry#home/registrationdetails/6246bfeeeaaed6001f08dadc/.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Delivery of Health Care, Integrated / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Traditional medicine Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0277936

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Delivery of Health Care, Integrated / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Traditional medicine Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0277936